These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 26755705)

  • 1. Identification of CD112R as a novel checkpoint for human T cells.
    Zhu Y; Paniccia A; Schulick AC; Chen W; Koenig MR; Byers JT; Yao S; Bevers S; Edil BH
    J Exp Med; 2016 Feb; 213(2):167-76. PubMed ID: 26755705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112).
    Tahara-Hanaoka S; Shibuya K; Onoda Y; Zhang H; Yamazaki S; Miyamoto A; Honda S; Lanier LL; Shibuya A
    Int Immunol; 2004 Apr; 16(4):533-8. PubMed ID: 15039383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poliovirus receptor (PVR)-like protein cosignaling network: new opportunities for cancer immunotherapy.
    Wu B; Zhong C; Lang Q; Liang Z; Zhang Y; Zhao X; Yu Y; Zhang H; Xu F; Tian Y
    J Exp Clin Cancer Res; 2021 Aug; 40(1):267. PubMed ID: 34433460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CD112R/CD112 axis: a breakthrough in cancer immunotherapy.
    Zeng T; Cao Y; Jin T; Tian Y; Dai C; Xu F
    J Exp Clin Cancer Res; 2021 Sep; 40(1):285. PubMed ID: 34507594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of T Cell Costimulation via DNAM-1 in Kidney Transplantation.
    Kraus AK; Chen J; Edenhofer I; Ravens I; Gaspert A; Cippà PE; Mueller S; Wuthrich RP; Segerer S; Bernhardt G; Fehr T
    PLoS One; 2016; 11(2):e0147951. PubMed ID: 26840537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of murine DNAM-1 (CD226) and its poliovirus receptor family ligands.
    Tahara-Hanaoka S; Miyamoto A; Hara A; Honda S; Shibuya K; Shibuya A
    Biochem Biophys Res Commun; 2005 Apr; 329(3):996-1000. PubMed ID: 15752754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-cell Receptor Signaling.
    Josefsson SE; Huse K; Kolstad A; Beiske K; Pende D; Steen CB; Inderberg EM; Lingjærde OC; Østenstad B; Smeland EB; Levy R; Irish JM; Myklebust JH
    Clin Cancer Res; 2018 Feb; 24(4):870-881. PubMed ID: 29217528
    [No Abstract]   [Full Text] [Related]  

  • 8. DNAM-1 ligand expression on Ag-stimulated T lymphocytes is mediated by ROS-dependent activation of DNA-damage response: relevance for NK-T cell interaction.
    Ardolino M; Zingoni A; Cerboni C; Cecere F; Soriani A; Iannitto ML; Santoni A
    Blood; 2011 May; 117(18):4778-86. PubMed ID: 21406724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The TIGIT/CD226 axis regulates human T cell function.
    Lozano E; Dominguez-Villar M; Kuchroo V; Hafler DA
    J Immunol; 2012 Apr; 188(8):3869-75. PubMed ID: 22427644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hitting the complexity of the TIGIT-CD96-CD112R-CD226 axis for next-generation cancer immunotherapy.
    Jin HS; Park Y
    BMB Rep; 2021 Jan; 54(1):2-11. PubMed ID: 33298247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased CD112 expression in methylcholanthrene-induced tumors in CD155-deficient mice.
    Nagumo Y; Iguchi-Manaka A; Yamashita-Kanemaru Y; Abe F; Bernhardt G; Shibuya A; Shibuya K
    PLoS One; 2014; 9(11):e112415. PubMed ID: 25384044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TIGIT-Fc alleviates acute graft-versus-host disease by suppressing CTL activation via promoting the generation of immunoregulatory dendritic cells.
    Zhang D; Hu W; Xie J; Zhang Y; Zhou B; Liu X; Zhang Y; Su Y; Jin B; Guo S; Zhuang R
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3085-3098. PubMed ID: 29960041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examination of the TIGIT-CD226-CD112-CD155 Immune Checkpoint Network during a Healthy Pregnancy.
    Meggyes M; Nagy DU; Feik T; Boros A; Polgar B; Szereday L
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142692
    [No Abstract]   [Full Text] [Related]  

  • 14. The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity.
    Stanietsky N; Simic H; Arapovic J; Toporik A; Levy O; Novik A; Levine Z; Beiman M; Dassa L; Achdout H; Stern-Ginossar N; Tsukerman P; Jonjic S; Mandelboim O
    Proc Natl Acad Sci U S A; 2009 Oct; 106(42):17858-63. PubMed ID: 19815499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranodal interaction with dendritic cells dynamically regulates surface expression of the co-stimulatory receptor CD226 protein on murine T cells.
    Seth S; Qiu Q; Danisch S; Maier MK; Braun A; Ravens I; Czeloth N; Hyde R; Dittrich-Breiholz O; Förster R; Bernhardt G
    J Biol Chem; 2011 Nov; 286(45):39153-63. PubMed ID: 21937446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse TIGIT inhibits NK-cell cytotoxicity upon interaction with PVR.
    Stanietsky N; Rovis TL; Glasner A; Seidel E; Tsukerman P; Yamin R; Enk J; Jonjic S; Mandelboim O
    Eur J Immunol; 2013 Aug; 43(8):2138-50. PubMed ID: 23677581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis.
    Pende D; Bottino C; Castriconi R; Cantoni C; Marcenaro S; Rivera P; Spaggiari GM; Dondero A; Carnemolla B; Reymond N; Mingari MC; Lopez M; Moretta L; Moretta A
    Mol Immunol; 2005 Feb; 42(4):463-9. PubMed ID: 15607800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of PVR/PVRL2 with TIGIT/DNAM-1 as a novel immune checkpoint axis and therapeutic target in cancer.
    Stamm H; Wellbrock J; Fiedler W
    Mamm Genome; 2018 Dec; 29(11-12):694-702. PubMed ID: 30132062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divergent Phenotypes of Human Regulatory T Cells Expressing the Receptors TIGIT and CD226.
    Fuhrman CA; Yeh WI; Seay HR; Saikumar Lakshmi P; Chopra G; Zhang L; Perry DJ; McClymont SA; Yadav M; Lopez MC; Baker HV; Zhang Y; Li Y; Whitley M; von Schack D; Atkinson MA; Bluestone JA; Brusko TM
    J Immunol; 2015 Jul; 195(1):145-55. PubMed ID: 25994968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examination of the TIGIT, CD226, CD112, and CD155 Immune Checkpoint Molecules in Peripheral Blood Mononuclear Cells in Women Diagnosed with Early-Onset Preeclampsia.
    Szereday L; Nagy DU; Csiszar B; Kevey D; Feik T; Meggyes M
    Biomedicines; 2021 Nov; 9(11):. PubMed ID: 34829838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.